The IPI Model: Breaking Down CMS’s Proposed Drug Pricing Model

Overview


Join McDermott for a Webinar on Changes to the Pharma Ecosystem

The Centers for Medicare and Medicaid Services (CMS)’s October 25 announcement of an Advanced Notice of Proposed Rulemaking with Comment proposes to implement an international pricing index model for Medicare Part B drugs and biologicals. This model has the potential to make sweeping changes to the entire pharmaceutical ecosystem.

Join McDermott Will & Emery’s Emily Cook and McDermott+Consulting’s John Warren as they lead a discussion on the impact of CMS’s proposed model and break down the implications on stakeholder groups from providers to drug manufacturers.

Click here to register.

For more information, please contact Jennifer Randles.

Dig Deeper

London, United Kingdom / McDermott Event / June 17, 2021

2021 European Healthcare Services Private Equity Leadership Forum

Webinar / Speaking Engagements / February 16, 2021

AIPLA's Patent Practice Innovation Webinar Series

Webinar / McDermott Event / January 26, 2021

Managed Care Spotlight: Recapping 2020 and Looking Ahead to 2021

Virtual Event Series / McDermott Event / January 21 – February 4, 2021

9th McDermott International Japan Seminar | Virtual Event Series